Esthetic, Clinical and Radiographic Outcomes of Immediately Placed Implants (Type 1) and Early Placed Implants (Type 2)

Sponsor
The University of Texas Health Science Center at San Antonio (Other)
Overall Status
Completed
CT.gov ID
NCT01623739
Collaborator
Institut Straumann AG (Industry)
38
1
2
65
0.6

Study Details

Study Description

Brief Summary

The investigators are asking subjects to take part in a research study of soft tissue (gums) and bone (jawbone) healing around dental implants following tooth extraction. The investigators want to compare how the gums and the bone changes shape with healing in two different scenarios:

  1. When the implant is placed at the same time the tooth is extracted.

  2. When the tooth is extracted and then left to heal for a period of 4 to 8 weeks before the implant is placed.

Previous studies have shown that both methods work and can give good results. In fact the two methods are used routinely as part of standard care but it is not known if the two procedures are equally good since they have never been compared in one same research study.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Placement of a dental implant
N/A

Detailed Description

This controlled, randomized clinical trial (RCT) is designed to compare soft and hard tissue dimensional changes for two commonly used approaches for replacing a recently extracted tooth by means of a dental implant, i.e. immediate implant placement (Type 1) or early implant placement (Type 2). Additionally, this study will evaluate the association between the osseous anatomy and implant position with soft and hard tissue changes.

Extraction sites will include maxillary and mandibular anterior and premolar teeth having intact adjacent teeth. Implants placed for this study will be SLA surface, bone level design, Straumann BL RC (Bone Level Regular Cross-fit ) 4.1mm or BL NC (Bone Level Narrow Cross-fit ) 3.3mm diameter implants at 8, 10, 12 or 14mm in length.

Immediate implant placement (Type 1) resulting in a horizontal defect dimension (HDD) will receive bone grafting, using freeze dried bone allograft (FDBA)(Straumann Allograft GC®) and will be covered by a resorbable membrane (BioGide®).

For the implants randomized to type 2 implant placement, the extraction socket will be filled with a collagen plug and allowed to heal for 4 to 8 weeks before the implant will be placed. Simultaneous guided bone regeneration (GBR) will be performed using FDBA (Straumann Allograft GC®)and a resorbable collagen membrane (BioGide®). The type 2 implant placement procedure will follow the guidelines as described by Buser et al. (2008).

All implant placement will follow standard protocols utilizing tapping and placement according to the manufacturer's guidelines.

Study Design

Study Type:
Interventional
Actual Enrollment :
38 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Esthetic, Clinical and Radiographic Outcomes of Immediately Placed Implants (Type 1) and Early Placed Implants (Type 2)
Study Start Date :
Dec 1, 2010
Actual Primary Completion Date :
May 1, 2016
Actual Study Completion Date :
May 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Type 1 implant placement

Placement of a dental implant: Implant is placed immediately following tooth extraction in one surgical procedure

Procedure: Placement of a dental implant
Type 1 implant placement Type 2 implant placement
Other Names:
  • Straumann
  • SLActive
  • Dental Implants
  • Active Comparator: Type 2 implant placement

    Placement of a dental implant: Once the tooth is extracted. The site is left to heal for 4 to 8 weeks before a dental implant is placed during a second surgical procedure.

    Procedure: Placement of a dental implant
    Type 1 implant placement Type 2 implant placement
    Other Names:
  • Straumann
  • SLActive
  • Dental Implants
  • Outcome Measures

    Primary Outcome Measures

    1. Mid Facial Mucosal Level at Implant Site [3 months after crown delivery]

      Baseline will be at the time of crown delivery. Thereafter, the mid facial mucosal level at implant site will be recorded at 3, 6, 12, 24, 36, 48, 60 months after crown delivery.

    Secondary Outcome Measures

    1. PES/WES (Pink Esthetic Score, White Esthetic Score). [3, 6, 12, 24, 36, 48, 60 months after crown delivery]

      The PES and WES scales are 10 point scales, made up of 5 categories, each with a 2 point value. Each category is scored out of 2, and the scores totaled to give an optimal score out of 10. Any score of 6 or higher out of 10 would be considered a good clinical outcome. the PES categories focus on the gum area, and the WES categories focus on the tooth. The scores for PES and WES are totaled, to give a score out of 20, with 20 being the highest possible score (best outcome). The values are totaled and a mean score of all the readings is reported.

    2. Probing Depth [3, 6, 12, 24, 36, 48, 60 months after crown delivery]

      The measurement of the pocket around the implanted tooth, measured with a graduated probe. A healthy pocket depth is around 3mm with no bleeding during the measurement process. The values are totaled and a mean score of all the readings is reported.

    3. Modified Plaque Index [3, 6, 12, 24, 36, 48, 60 months after crown delivery]

      Measurement of amount of plaque build-up on teeth, using a scale of 0 (no plaque detection), to 3 (an abundance of soft matter). The scores are totaled and a mean score reported.

    4. Modified Bleeding Index [3, 6, 12, 24, 36, 48, 60 months after crown delivery]

      Bleeding from the gums is measured on probing the gum and measured on scale of 0 to 5, with 0 being the best outcome, with no bleeding, and 5 being the worst outcome, with spontaneous bleeding. The scores are totaled and a mean score reported.

    5. Radiographic Bone Level [Up to 5 years after baseline]

      Secondary outcome measures will be recorded at 3, 6, 12, 24, 36, 48, 60 months after crown delivery.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    1. The patient is 18 years or older.

    2. Ability to understand and provide informed consent before starting the study.

    3. Ability and willingness to comply with all study requirements.

    4. The patient, if of child-bearing potential, has a negative urine pregnancy test.

    5. Adequate oral hygiene to allow for implant therapy consistent with standards of care.

    6. Adequate bone volume to accommodate the planned endosseous dental implant placement following immediate placement protocols utilizing Straumann Bone Level implants RC 4.1mm or Bone Level Implant NC 3.3 mm at 8, 10, 12 or 14 mm in length.

    7. One or more teeth in either the maxilla or mandible anterior or premolar areas requiring extraction leading to a single-tooth gap requiring implant placement as determined by the patient's dental provider.

    8. Following extraction, surgical site anatomy presents conditions allowing immediate implant placement.

    9. Primary stability of implant consistent with standards of care is achieved at the time of placement.

    Exclusion Criteria:
    1. Patient reports current smoking habit with moderate or heavy smoking (more than 10 cigarettes per day) or tobacco chewing use.

    2. History of alcoholism or drug abuse within the past 5 years.

    3. Severe bruxism or clenching habits.

    4. Patient has significant untreated periodontal disease (grade III or IV), caries, or clinical or radiographic signs of infection within two adjacent tooth positions of implant area.

    5. History of HIV infection, Hepatitis B or C.

    6. Patients with a history of systemic disease that precludes standard dental implant therapy or alters daily activities to a level consistent with ASA III classification (including cardiovascular, hepatic, renal, gastrointestinal, metabolic, neurologic, pulmonary, endocrine, autoimmune, or psychiatric disorders).

    7. Presence of local inflammation or mucosal diseases such as lichen planus

    8. Patient history consistent with high risk for subacute bacterial endocarditis

    9. Current hematological disorder or coumadin (or similar) therapy

    10. Patient has a disease that affects bone metabolism, such as but not limited to osteoporosis, hyperthyroidism, hyperparathyroidism, congenital connective tissue disorders (e.g., osteogenesis imperfecta), or Paget's disease.

    11. Patient is taking medications or having treatments known to have an effect on bone turnover, including: thiazide diuretics, calcitonin, systemic steroids, bisphosphonates, vitamin D (>800 IU/day), estrogen or progesterone therapy.

    12. Current steroid treatment: defined as any person who within the last two years has received for two weeks a dose equivalent to 20 mg hydrocortisone

    13. Patient currently undergoing chemotherapy

    14. Patient history of radiation treatment to the head or neck

    15. Physical or mental handicaps that would interfere with patient's ability to exercise good oral hygiene on a regular basis

    16. Use of any investigational drug or device within the 30 day period immediately prior to implant surgery

    17. Patient is pregnant

    18. Extraction sites having anatomic conditions that preclude immediate implant placement.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Graduate Periodontics, Dental School, UTHSCSA San Antonio Texas United States 78229

    Sponsors and Collaborators

    • The University of Texas Health Science Center at San Antonio
    • Institut Straumann AG

    Investigators

    • Principal Investigator: Guy Huynh-Ba, DDS, MS, UTHSCSA Department of Periodontics

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    The University of Texas Health Science Center at San Antonio
    ClinicalTrials.gov Identifier:
    NCT01623739
    Other Study ID Numbers:
    • ITI 689_2010
    First Posted:
    Jun 20, 2012
    Last Update Posted:
    Sep 25, 2018
    Last Verified:
    Oct 1, 2017
    Keywords provided by The University of Texas Health Science Center at San Antonio
    Additional relevant MeSH terms:

    Study Results

    Participant Flow

    Recruitment Details
    Pre-assignment Detail
    Arm/Group Title Type 1 Implant Placement Type 2 Implant Placement
    Arm/Group Description Implant is placed immediately following tooth extraction in one surgical procedure Placement of a dental implant: Type 1 implant placement Type 2 implant placement Once the tooth is extracted. The site is left to heal for 4 to 8 weeks before a dental implant is placed during a second surgical procedure. Placement of a dental implant: Type 1 implant placement Type 2 implant placement
    Period Title: Overall Study
    STARTED 19 19
    COMPLETED 17 15
    NOT COMPLETED 2 4

    Baseline Characteristics

    Arm/Group Title Type 1 Implant Placement Type 2 Implant Placement Total
    Arm/Group Description Implant is placed immediately following tooth extraction in one surgical procedure Placement of a dental implant: Type 1 implant placement Type 2 implant placement Once the tooth is extracted. The site is left to heal for 4 to 8 weeks before a dental implant is placed during a second surgical procedure. Placement of a dental implant: Type 1 implant placement Type 2 implant placement Total of all reporting groups
    Overall Participants 17 15 32
    Age (years) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [years]
    52.5
    (15.6)
    50.9
    (14.6)
    51.8
    (14.9)
    Sex: Female, Male (Count of Participants)
    Female
    8
    47.1%
    6
    40%
    14
    43.8%
    Male
    9
    52.9%
    9
    60%
    18
    56.3%
    Race and Ethnicity Not Collected (Count of Participants)
    Count of Participants [Participants]
    0
    0%
    Region of Enrollment (participants) [Number]
    United States
    17
    100%
    15
    100%
    32
    100%

    Outcome Measures

    1. Primary Outcome
    Title Mid Facial Mucosal Level at Implant Site
    Description Baseline will be at the time of crown delivery. Thereafter, the mid facial mucosal level at implant site will be recorded at 3, 6, 12, 24, 36, 48, 60 months after crown delivery.
    Time Frame 3 months after crown delivery

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Type 1 Implant Placement Type 2 Implant Placement
    Arm/Group Description Implant is placed immediately following tooth extraction in one surgical procedure Placement of a dental implant: Type 1 implant placement Type 2 implant placement Once the tooth is extracted. The site is left to heal for 4 to 8 weeks before a dental implant is placed during a second surgical procedure. Placement of a dental implant: Type 1 implant placement Type 2 implant placement
    Measure Participants 17 15
    Mean (Standard Deviation) [mm]
    0.54
    (0.18)
    0.47
    (0.31)
    2. Secondary Outcome
    Title PES/WES (Pink Esthetic Score, White Esthetic Score).
    Description The PES and WES scales are 10 point scales, made up of 5 categories, each with a 2 point value. Each category is scored out of 2, and the scores totaled to give an optimal score out of 10. Any score of 6 or higher out of 10 would be considered a good clinical outcome. the PES categories focus on the gum area, and the WES categories focus on the tooth. The scores for PES and WES are totaled, to give a score out of 20, with 20 being the highest possible score (best outcome). The values are totaled and a mean score of all the readings is reported.
    Time Frame 3, 6, 12, 24, 36, 48, 60 months after crown delivery

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Type 1 Implant Placement Type 2 Implant Placement
    Arm/Group Description Implant is placed immediately following tooth extraction in one surgical procedure Placement of a dental implant: Type 1 implant placement Type 2 implant placement Once the tooth is extracted. The site is left to heal for 4 to 8 weeks before a dental implant is placed during a second surgical procedure. Placement of a dental implant: Type 1 implant placement Type 2 implant placement
    Measure Participants 17 15
    Mean (Standard Error) [units on a scale]
    13.67
    (0.61)
    12.51
    (0.65)
    3. Secondary Outcome
    Title Probing Depth
    Description The measurement of the pocket around the implanted tooth, measured with a graduated probe. A healthy pocket depth is around 3mm with no bleeding during the measurement process. The values are totaled and a mean score of all the readings is reported.
    Time Frame 3, 6, 12, 24, 36, 48, 60 months after crown delivery

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Type 1 Implant Placement Type 2 Implant Placement
    Arm/Group Description Implant is placed immediately following tooth extraction in one surgical procedure Placement of a dental implant: Type 1 implant placement Type 2 implant placement Once the tooth is extracted. The site is left to heal for 4 to 8 weeks before a dental implant is placed during a second surgical procedure. Placement of a dental implant: Type 1 implant placement Type 2 implant placement
    Measure Participants 17 15
    Mean (Standard Error) [mm]
    3.06
    (0.18)
    2.93
    (0.18)
    4. Secondary Outcome
    Title Modified Plaque Index
    Description Measurement of amount of plaque build-up on teeth, using a scale of 0 (no plaque detection), to 3 (an abundance of soft matter). The scores are totaled and a mean score reported.
    Time Frame 3, 6, 12, 24, 36, 48, 60 months after crown delivery

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Type 1 Implant Placement Type 2 Implant Placement
    Arm/Group Description Implant is placed immediately following tooth extraction in one surgical procedure Placement of a dental implant: Type 1 implant placement Type 2 implant placement Once the tooth is extracted. The site is left to heal for 4 to 8 weeks before a dental implant is placed during a second surgical procedure. Placement of a dental implant: Type 1 implant placement Type 2 implant placement
    Measure Participants 17 15
    Mean (Standard Error) [units on a scale]
    0.18
    (0.10)
    0.27
    (0.15)
    5. Secondary Outcome
    Title Modified Bleeding Index
    Description Bleeding from the gums is measured on probing the gum and measured on scale of 0 to 5, with 0 being the best outcome, with no bleeding, and 5 being the worst outcome, with spontaneous bleeding. The scores are totaled and a mean score reported.
    Time Frame 3, 6, 12, 24, 36, 48, 60 months after crown delivery

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Type 1 Implant Placement Type 2 Implant Placement
    Arm/Group Description Implant is placed immediately following tooth extraction in one surgical procedure Placement of a dental implant: Type 1 implant placement Type 2 implant placement Once the tooth is extracted. The site is left to heal for 4 to 8 weeks before a dental implant is placed during a second surgical procedure. Placement of a dental implant: Type 1 implant placement Type 2 implant placement
    Measure Participants 17 15
    Mean (Standard Error) [units on a scale]
    0.12
    (0.08)
    0.07
    (0.07)
    6. Secondary Outcome
    Title Radiographic Bone Level
    Description Secondary outcome measures will be recorded at 3, 6, 12, 24, 36, 48, 60 months after crown delivery.
    Time Frame Up to 5 years after baseline

    Outcome Measure Data

    Analysis Population Description
    No data were collected or analyzed for this outcome measure
    Arm/Group Title Radiographic Bone Level
    Arm/Group Description Radiography is used to measure amount of bone
    Measure Participants 0

    Adverse Events

    Time Frame Up to 3 months after crown delivery
    Adverse Event Reporting Description
    Arm/Group Title Type 1 Implant Placement Type 2 Implant Placement
    Arm/Group Description Implant is placed immediately following tooth extraction in one surgical procedure Placement of a dental implant: Type 1 implant placement Type 2 implant placement Once the tooth is extracted. The site is left to heal for 4 to 8 weeks before a dental implant is placed during a second surgical procedure. Placement of a dental implant: Type 1 implant placement Type 2 implant placement
    All Cause Mortality
    Type 1 Implant Placement Type 2 Implant Placement
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/17 (0%) 0/15 (0%)
    Serious Adverse Events
    Type 1 Implant Placement Type 2 Implant Placement
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/17 (0%) 0/15 (0%)
    Other (Not Including Serious) Adverse Events
    Type 1 Implant Placement Type 2 Implant Placement
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/17 (0%) 2/15 (13.3%)
    Surgical and medical procedures
    Swelling and bruising 0/17 (0%) 0 2/15 (13.3%) 2

    Limitations/Caveats

    [Not Specified]

    More Information

    Certain Agreements

    Principal Investigators are NOT employed by the organization sponsoring the study.

    There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

    Results Point of Contact

    Name/Title Guy Huynh-Ba
    Organization UTHSCSA Periodontics
    Phone 2105673569
    Email huynhba@uthscsa.edu
    Responsible Party:
    The University of Texas Health Science Center at San Antonio
    ClinicalTrials.gov Identifier:
    NCT01623739
    Other Study ID Numbers:
    • ITI 689_2010
    First Posted:
    Jun 20, 2012
    Last Update Posted:
    Sep 25, 2018
    Last Verified:
    Oct 1, 2017